Skip to content

Small Fiber Assessment by Cutaneous Silent Period

Small Peripheral Fibers Assessment Using Cutaneous Silent Period In Normal Individuals In Egypt

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04863820
Enrollment
64
Registered
2021-04-28
Start date
2021-04-27
Completion date
2021-10-30
Last updated
2021-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small Fiber Neuropathy

Brief summary

Our primary objective in this study is to investigate the cutaneous silent period (CSP) in normal subjects in the Egyptian population, as it was not carried out before in Egypt. The aim was to carry out the test in our unit to study the appropriate method, technique, and parameters of this new test so that we can apply it in future research. In addition, to obtain preliminary normative data of the test; onset latency, end latency, duration, and latency difference (LD) of CSP, as well as assess the effect of age, height, upper limb length, and gender on CSP values.

Detailed description

Nerve conduction studies performed routinely in electromyoneurography laboratories deal mainly with large myelinated fast conducting nerve fibers. A reliable method allowing the study of small peripheral nerve fibers (Aδ & C) would be of interest (Jovita et al., 2006). As they are initially affected and maybe the earliest exhibited sign of neuropathy. In recent years, the cutaneous silent period (CSP) has received increased attention in health and disease. The CSP is an inhibitory spinal reflex that appears following strong electrical stimulation of the cutaneous nerve and causes suppression of voluntary muscular contraction for a certain period of time (Kofler et al., 2019). This action presents a reciprocal action to the nociceptive flexor withdrawal response (FWR) which serves as an 'excitatory reflex' increasing activity in primary flexor muscles. When taken into context, the interplay between the CSP and FWR can clearly be seen. The evaluation of the CSP represents a useful electrophysiological method for investigating the function of small fibers by using standard electromyography equipment (Eckert et al., 2018).

Interventions

form of Nerve conduction studies

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy participants able to cooperate and to follow instructions. * Participants having a normal value for electrophysiological parameters (Nerve conduction studies) * Participants must be free from any musculoskeletal impairment of the limbs

Exclusion criteria

* Participants with neurological disorders * Participants with cognitive impairment * Participants receiving medications that may affect the NCS * Participants with small fiber neuropathy (burning sensation, pricking sensation, allodynia, and hyperalgesia) * Participants with an abnormal value for Nerve conduction studies * Participants with musculoskeletal impairment of the limbs

Design outcomes

Primary

MeasureTime frameDescription
Normative parameters of cutaneous silent period of the median, ulnar , and sural nerves (measured in milli second)1 yearestablishing Normative of CSP enables the diagnosis of small fiber neuriopathy in the future The CSP parameters include: CSP onset latency,CSP end latency, and CSP duration (measured in ms; milli second)

Countries

Egypt

Contacts

Primary ContactSarah M Kaddah, MSc
SarahKaddah@hotmail.com002 01226444168
Backup ContactLamia M Afifi, Professor
lafifi2@kasralainy.edu.eg002 01223938134

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026